CRP and congestive heart failure: Recently, there has been renewed interest and data supporting the use of thrombo-inflammatory markers obtained from routine complete blood counts, such as the neutrophil/lymphocyte ratio and the platelet/lymphocyte ratio, as well as other thrombo-inflammatory biomarkers, including C-reactive protein (CRP) and D-dimer, as prognostic tools in CHF patients [25,26,27,28,29,30,31].